Press coverage about PerkinElmer (NYSE:PKI) has trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. PerkinElmer earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave media headlines about the medical research company an impact score of 46.279723068812 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the news stories that may have impacted Accern Sentiment Analysis’s scoring:
- PerkinElmer, Inc. (United States) – Value Analysis (NYSE:PKI) : December 6, 2017 (finance.yahoo.com)
- PerkinElmer and TeakOrigin Team up to Provide Enhanced Transparency in Food (tmcnet.com)
- PerkinElmer, Inc. (PKI) set in line stellar 11.23% in next 2017-2022 – Morning Outlook (morningoutlook.com)
- PerkinElmer, Inc. (United States) breached its 50 day moving average in a Bearish Manner : PKI-US : December 5, 2017 (finance.yahoo.com)
- $615.80 Million in Sales Expected for PerkinElmer, Inc. (PKI) This Quarter (americanbankingnews.com)
Several research analysts have recently commented on the company. Goldman Sachs Group reissued a “neutral” rating and set a $67.00 price objective on shares of PerkinElmer in a report on Tuesday, September 26th. Robert W. Baird restated a “buy” rating and issued a $72.00 target price on shares of PerkinElmer in a research report on Friday, October 20th. Cowen restated a “hold” rating and issued a $70.00 target price on shares of PerkinElmer in a research report on Friday, September 1st. ValuEngine downgraded PerkinElmer from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Finally, Morgan Stanley restated an “overweight” rating and issued a $77.00 target price (down previously from $79.00) on shares of PerkinElmer in a research report on Friday, October 6th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and six have assigned a buy rating to the company’s stock. PerkinElmer currently has an average rating of “Hold” and a consensus price target of $68.64.
Shares of PerkinElmer (PKI) traded up $0.18 during mid-day trading on Wednesday, reaching $69.54. The company’s stock had a trading volume of 616,114 shares, compared to its average volume of 632,414. The company has a quick ratio of 2.09, a current ratio of 2.59 and a debt-to-equity ratio of 0.44. PerkinElmer has a 12-month low of $50.59 and a 12-month high of $74.11. The company has a market capitalization of $7,691.51, a P/E ratio of 25.10, a P/E/G ratio of 2.09 and a beta of 0.77.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Friday, January 19th will be given a $0.07 dividend. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.28 annualized dividend and a yield of 0.40%. PerkinElmer’s payout ratio is currently 7.78%.
In other news, Director Nicholas A. Lopardo sold 24,050 shares of the business’s stock in a transaction that occurred on Tuesday, November 7th. The stock was sold at an average price of $70.72, for a total transaction of $1,700,816.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Alexis P. Michas sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $73.18, for a total value of $365,900.00. The disclosure for this sale can be found here. Insiders have sold 36,121 shares of company stock worth $2,569,252 over the last three months. Insiders own 2.20% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact PerkinElmer (NYSE:PKI) Stock Price” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://ledgergazette.com/2017/12/07/perkinelmer-pki-earns-daily-media-sentiment-rating-of-0-17.html.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.